Korea Arlico Pharm Co.,Ltd. (KOSDAQ: 260660)

Korea Arlico Pharm Co.,Ltd. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	53,108	87,364	100,392	117,712	142,830	137,624
Market Cap Growth	-32.59%	-12.98%	-14.71%	-17.59%	3.78%	16.13%
Enterprise Value	83,899	102,863	93,513	100,409	140,080	129,716
Last Close Price	3465.00	5700.00	6403.19	7360.87	8769.42	8442.70
PE Ratio	-	28.54	12.50	23.88	17.06	13.72
PS Ratio	0.28	0.47	0.60	0.84	1.14	1.19
PB Ratio	0.62	0.98	1.13	1.45	1.84	1.93
P/TBV Ratio	0.81	1.06	1.23	1.53	1.95	2.04
P/FCF Ratio	-	-	-	31.82	-	13.12
P/OCF Ratio	-	12.22	20.76	13.13	31.42	10.48
EV/Sales Ratio	0.46	0.55	0.56	0.72	1.12	1.12
EV/EBITDA Ratio	-	13.11	7.21	13.57	11.09	9.10
EV/EBIT Ratio	-	33.48	9.48	20.94	13.22	10.35
EV/FCF Ratio	-5.70	-	-	27.14	-	12.37
Debt / Equity Ratio	0.55	0.52	0.35	0.16	0.13	0.35
Debt / EBITDA Ratio	-	5.90	2.40	1.70	0.77	1.74
Debt / FCF Ratio	-	-	-	3.41	-	2.36
Asset Turnover	1.12	1.14	1.22	1.21	1.09	1.01
Inventory Turnover	2.82	2.84	2.58	2.72	2.87	3.45
Quick Ratio	0.61	0.76	0.91	1.43	1.44	1.56
Current Ratio	1.17	1.19	1.43	2.04	2.15	1.90
Return on Equity (ROE)	-8.48%	3.45%	9.47%	6.21%	11.25%	15.10%
Return on Assets (ROA)	-3.58%	1.17%	4.49%	2.59%	5.78%	6.83%
Return on Capital (ROIC)	-4.49%	1.51%	5.78%	3.31%	7.23%	8.29%
Earnings Yield	-14.47%	3.50%	8.00%	4.19%	5.86%	7.29%
FCF Yield	-27.73%	-18.59%	-14.08%	3.14%	-3.39%	7.62%
Payout Ratio	0.00%	63.76%	13.08%	19.43%	22.89%	-
Buyback Yield / Dilution	11.75%	-11.57%	-0.18%	0.06%	-51.13%	-8.20%
Total Shareholder Return	11.75%	-11.57%	-0.18%	0.06%	-51.13%	-8.20%

Source: S&P Capital IQ. Standard template. Financial Sources.